DEEPTI VATS: Open Payments
NPI 1932496262 · TERRELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 26 payments from 7 companies in 2025. Trend: 2023 $696 · 2024 $1,494 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $118 |
| ABBVIE INC. | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
Products named: REXULTI, TRINTELLIX, VRAYLAR, Auvelity, CAPLYTA, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
